Salvianolic Acid B Alleviates Lipopolysaccharide-Induced Intestinal Barrier Dysfunction by Restoring Epithelial Proliferation–Apoptosis Balance and Modulating the Gut Microbiota
Antioxidants · 03.11.2026 · 15 (11) · 1425
DOI: 10.3390/antiox15111425 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antioxidants, online erschienen am 03.11.2026. Verfasst von Yuxin Jiang und 8 weiteren Autor:innen. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Jiangsu Province, National Natural Science Foundation of China, Jiangsu Provincial Young Science and Technology Talent Support Program.
Abstract (Originalsprache)
Background
Intestinal epithelial barrier dysfunction, a major consequence of inflammatory and oxidative stress, contributes to enteric disorder progression. Salvianolic acid B (SAB), a prominent water-soluble phenolic compound in Salvia miltiorrhiza, shows intestinal protective potential, but the underlying mechanisms remain unclear.
Methods
This study investigated the protective effects of SAB on intestinal barrier function using a lipopolysaccharide (LPS)-challenged piglet model and LPS-stimulated IPEC-J2 cells.
Results
SAB alleviated LPS-induced intestinal injury, evidenced by reduced plasma diamine oxidase and D-lactate levels, improved intestinal morphology, decreased pro-inflammatory cytokines, and enhanced antioxidant capacity. SAB also strengthened intestinal barrier integrity by increasing goblet cell number and mucin 2 levels and upregulating tight junction protein expression. Moreover, SAB restored epithelial proliferation–apoptosis balance and increased PI3K/AKT/mTOR phosphorylation. Molecular docking and molecular dynamics simulations predicted a stable SAB–PI3Kα/p110α interaction, whereas LY294002 treatment attenuated SAB-mediated restoration of epithelial renewal and barrier integrity in LPS-treated IPEC-J2 cells. SAB also altered the jejunal microbial composition, including higher relative abundance of Streptococcus and lower relative abundance of Escherichia-Shigella, together with increased jejunal acetate and lactate concentrations.
Conclusions
SAB alleviates inflammation-associated intestinal barrier dysfunction by restoring epithelial proliferation–apoptosis balance and regulating the microbiota–metabolite profile.
Förderung
- Natural Science Foundation of Jiangsu Province
- National Natural Science Foundation of China
- Jiangsu Provincial Young Science and Technology Talent Support Program
Zitieren
APA
Jiang, Y., Xie, H., Zhang, H., Zhang, J., Yu, Y., Chen, Y., Wang, H., Lai, C., & Yong, Q. (2026). Salvianolic Acid B Alleviates Lipopolysaccharide-Induced Intestinal Barrier Dysfunction by Restoring Epithelial Proliferation–Apoptosis Balance and Modulating the Gut Microbiota. Antioxidants, 15(11), 1425. https://doi.org/10.3390/antiox15111425
Vancouver
Jiang Y, Xie H, Zhang H, Zhang J, Yu Y, Chen Y, et al. Salvianolic Acid B Alleviates Lipopolysaccharide-Induced Intestinal Barrier Dysfunction by Restoring Epithelial Proliferation–Apoptosis Balance and Modulating the Gut Microbiota. Antioxidants. 2026;15(11):1425. doi:10.3390/antiox15111425
BibTeX
@article{Jiang2026,
author = {Jiang, Yuxin and Xie, Huan and Zhang, Hao and Zhang, Jinsong and Yu, Yanfei and Chen, Yanan and Wang, Hao and Lai, Chenhuan and Yong, Qiang},
title = {Salvianolic Acid B Alleviates Lipopolysaccharide-Induced Intestinal Barrier Dysfunction by Restoring Epithelial Proliferation–Apoptosis Balance and Modulating the Gut Microbiota},
journal = {Antioxidants},
year = {2026},
volume = {15},
number = {11},
pages = {1425},
doi = {10.3390/antiox15111425}
}
EUVIMED